Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

US stocks climb as Treasury yields ease after key Fed inflation measure cools

Published 12/19/2024, 10:29 PM
Updated 12/20/2024, 01:23 PM
© Reuters.
ESH25
-
1YMH25
-
NQH25
-

Investing.com-- US stocks rallied Friday, underpinned by falling Treasury yields as cooler-than-expected inflation data eased concern that the Federal Reserve could turn even more hawkish next year.

At 1:22 p.m. ET (18:22 GMT), the Dow Jones Industrial Average rose 673 points, or 1.6%, the S&P 500 index gained 1.5%, and the NASDAQ Composite added 1.4%.

PCE cooler than expected

Treasury yields fell after data showing that inflation cooled in November, eased investor fears of an even more hawkish Federal Reserve next year.

The widely-watched PCE price index release, the Fed’s preferred inflation gauge, rose 2.4% in November on an annual basis, compared with estimates of 2.5%. On a monthly basis, it rose just 0.1%.

Excluding volatile food and energy components, the core PCE rose 2.8%, compared with estimates of 2.9%.

This release calmed some concerns as upside risks to inflation were back on the Fed's radar, with US consumer prices increasing by the most in seven months in November, and the potential for the new Donald Trump administration to authorise trade and tax policies that many see as inflationary.

"[W]e think the 12-month pace of core PCE will resume its downward trend in 1Q25 and, consequently, that the Fed will cut 25bp in March 2025," Morgan Stanley (NYSE:MS) said in a recent note.

FedEx to spin off freight business

In corporate news, FedEx (NYSE:FDX) stock climbed 0.5% after the delivery giant reported better-than-expected earnings in the fiscal second quarter, while also announcing that it’s planning on spinning off its freight business.

Nike (NYSE:NKE) stock fell 0.7% after the sportswear retailer flagged "severe issues" in its guidance, despite second-quarter results topping expectations.

Novo Nordisk A/S (NYSE:NVO) fell more than 16% after results from a late-stage study showed the drugmaker's weight-loss drug fell short of expectations. 

US government shutdown looms

The threat of a US government slowdown was raised Thursday after a Republican bill that included Donald Trump’s demands for higher government spending and a raised debt ceiling was rejected in a vote in the House of Representatives, with several Republican senators also openly defying the President-elect. 

The new bill replaced a bipartisan deal to approve government spending, after Trump and tech billionaire Elon Musk came out in opposition of the old deal. 

Government funding is set to expire at midnight on Friday, marking the beginning of a partial government shutdown that could disrupt operations ranging from border security to travel. The disruption is expected to be particularly dire amid increased travel trends during the holiday season. 

A government shutdown presents another layer of uncertainty for Wall Street, which was already nursing steep losses from earlier this week after the Federal Reserve cut interest rates but flagged a substantially slower pace of rate cuts in 2025. 

(Peter Nurse, Ambar Warrick contributed to this article.)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.